Blue Horseshoe Stocks: SPY Ripping & More

SPDR S&P 500 ETF (SPY)

Fresh for yesterday’s premarket report was an idea we formulated for the SPY after it appeared we were headed for another bullish session, the SPY Weekly $270-272 Calls. When the markets behaved as we suspected they would, that provided us with some really great chances for single-session profits in our target contracts.

The gains were strong across the board, with the following excellent moves being made on the day:

$270 Calls – Range: .85-3.44 – Max Gain: 304%
$270.50 Calls – Range: .70-2.98 – Max Gain: 326%
$271 Calls – Range: .52-2.59 – Max Gain: 398%
$271.50 Calls – Range: .39-2.14 – Max Gain: 449%
$272 Calls – Range: .30-1.78 – Max Gain: 493%

Today, if the bonanza continues, we’ll look to roll up our strike prices to the 272.50-274 Calls today.


Under Armour, Inc. UAA – Final Update

This is the fourth day this week we’ve been tracking our UAA calls that we submitted in our premarket report on Tuesday, the UAA Weekly $15.50-16.50 Calls. We wanted to circle back around one last time to provide an update on the ranges we observed this week.

The lows listed represent those from Tuesday, and the highs were all registered yesterday, so the percentage figures given represent a three day overall upswing:

$15.50 Calls – Range: .60-2.85 – Max Gain: 375%
$16 Calls – Range: .34-2.38 – Max Gain: 600%
$16.50 Calls – Range: .16-2.00 – Max Gain: 1150%
_______

Fresh Options Ideas

Deere & Co. DE Weekly $167.50 Calls*
The Coca-Cola Co. KO Weekly $45* & 02/23 $46 Calls

*Please do not attempt to trade weekly options on a Friday unless you are an expert level trader with disposable funds.


Extended Watchlist:
NVAX, NSPR, MULE, SDRL, WEN, BPMX, AXL, HK(Form-4 Buy)

Blue Horseshoe Stocks: XXII Update & More

22nd Century Group, Inc. XXII

It was back on November 7th that we highlighted a large group of cannabis stocks, and professed our unyielding interest in the space as a whole. XXII was among those that we specifically highlighted as promising pot stocks in that report, and despite it being more than 8 weeks later, the stock has continually bulled its ways to new highs ever since.

We wanted to swing back around this morning to outline the excellent run it has been on since November. Subsequent to our report on the 7th the stock saw an absolute bottom of 2.00 even before beginning its months-long ascent. Yesterday the stock reached yet another new high of 3.85, marking an overall upswing of 93%


Yield10 Bioscience, Inc. YTEN

Following a huge single session run in early December, YTEN was unable to hold onto any of the ground it had gained, and with the ‘help’ of a massive public offering, continued to descend until recently.

This week, the stock has begun to show signs of a bottom bounce, and we’re going to want to add it to the radar on a recovery watch. As you can see form the chart snapshot included below, there is a lot of room for a potential surge, including a gap to fill to the upside.


Extended Watchlist:
NVAX, RKDA, SDRL, CRBP, SQ, CHFS, NBEV, SIEN, CNET

Blue Horseshoe Stocks: TRXC Recap, Bottom Play & More

 TransEnterix, Inc. TRXC

We caught TRXC for a pretty nice move earlier this month, when we alerted it on the 16th, and the stock went on a two-day run from 2.15 to 4.43, scoring us a solid double-bagger.

In the weeks since then, TRXC has been under consolidation, and yesterday, we tagged it once again in our extended watchlist, and the stock produced what may be the start of another solid uptrend.

From a low of 2.50, the stock went as high as 3.03, making for a 21% rise on the day, and it maintained more than half of that move into the close on better-than-average volume.

We’ll continue to monitor for the establishment of higher highs and higher lows as TRXC attempts to get its next leg-up.


Immune Design Corp. IMDZ

We’ve got an interesting bottom setup on IMDZ, which recently took a massive downturn following the announcement of a large $80M public offering at a price of 4.10/share.

It’s also important to note that there was a huge $10M block of insider buying that came in on Friday near the lows.

Additionally, as you can see on the chart, the result of the last week of activity is a highly oversold state, and all indications seems to be pointing to the possibility of the stock regaining at least a portion of the ground it has recently lost.

Lastly, the company will be a hosting a post-market conference call tomorrow to discuss 3Q earnings and recent developments that you can tune into at http://ir.immunedesign.com/events.cfm after market close tomorrow and for 30 days thereafter.

As an added idea, we’ll radar the IMDZ 12/15 $5 Calls for observation in the days and weeks ahead. Those could see some nice activity if the stock has the recovery we suspect it might.


Extended Watchlist:
APTI, IDTI, IDRA, CGNX, MDLZ, SNE, NVAX, AMD(Bottom-Watch)